Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer.

International journal of oncology - 1 Oct 2005

Schirrmacher Volker, Beckhove Philipp, Choi Carmen, Griesbach Andreas, Mahnke Yolanda

Abstract excerpt

The bone marrow has been shown to represent a unique microenvironment where T cell immune responses against tumor associated antigens can be initiated and tumor-immune memory T cells are enriched. In the present study the graft versus leukemia (GvL) reactivity of bone marrow derived tumor-immune memory T cells was analyzed in an allogeneic minor histocompatibility different murine GvL tumor model with late stage...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD8-Positive T-Lymphocytes

Share to Immune System

Share to Immunologic Memory

Share to Mice, Inbred DBA

Share to Neoplasm Metastasis

Share to Spleen

Source

Identifiers

PMID: 16142333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer.PMID 16142333Read ↗

Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusionsSemantic proximity Read ↗

Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.Semantic proximity Read ↗

CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.Semantic proximity Read ↗

T helper 2-dominant antilymphoma immune response is associated with fatal outcome.Semantic proximity Read ↗

Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.Semantic proximity Read ↗

Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice.Semantic proximity Read ↗

Cross-protective murine graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines.Semantic proximity Read ↗

Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation.Semantic proximity Read ↗

Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell–mediated graft-versus-host disease modelSemantic proximity Read ↗

Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.